Europe's larges single-site cancer centre selects Better Meds' electronic prescribing and medicines administration system
The Christie's adoption of ePMA technology will enable clinical staff able to access medications from within the EHR, providing a better user experience and increased efficiency
The Christie NHS Foundation Trust has selected Better Meds for its electronic prescribing and medicines administrations (ePMA) solution.
This follows the successful implementation of Better’s digital health platform and low-code studio throughout the organisation.
The procurement marks the latest advancement of the trust’s bid to move to a new data-centric model with openEHR standards at its core.
The strategy involves modernising systems from a previous siloed-state where data is locked within applications to a data archetype model which facilitates a patient-centric approach.
The Christie is Europe’s largest single-site cancer centre, serving a population of over 3.2 million people and treating 60,000 patients each year.
It is a research-intensive institution and, as such, the integrity of, and access to, timely data is critical. This, in combination with the drive for all trusts to implement ePMA, meant adoption of an ePMA solution was a key priority.
Alistair Reid-Pearson, chief information officer at The Christie, said: “Digitally enabling clinical services is the primary mission in our Digital Strategy.
“We needed a module that could level up our core capabilities while also plugging into our openEHR data platform.
“The data-centric approach to continuously improve clinical outcomes is pivotal to the strategy.”
Vanessa Clay, the hospital’s clinical director for acute and support services, added: “Having a system that is easy to use and lowers the training requirements was a central objective of the selection process.
“Implementing an intuitive web-based system that makes it as easy as possible for clinicians is going to be a key principle of the project going forwards and from the outset.”
This latest contract will enable us to support The Christie as it continues to progress its openEHR digital strategy which will provide multiple benefits including better access to data and information, faster decision-making, and more-efficient management
And Damian Child, chief pharmacist, said: “We selected Better Meds as we wanted a system that provided core prescribing capabilities, but where careful consideration was also given to future capabilities.
“One example includes secondary care Electronic Prescription Service (EPS) connectivity which allows prescriptions to be sent digitally to community pharmacists.”
The Better Meds solution is built on the Better openEHR platform which underpins the trust’s in-house electronic health record (EHR).
It will facilitate a seamless embedded user interface with clinical staff able to access the medications from within the EHR providing a better user experience and increased efficiency.
The project also plans to integrate the trust’s chemotherapy prescribing system into the Better digital health platform.
iQHealthTech, the supplier of iQemo, has committed to move to openEHR storage standards for key clinical data items. This will facilitate a single source of truth for allergies, height, weight, and prescribing data, giving clinicians a complete patient overview and enabling sharing between modules.
Adrian Aggett, client director at Better UK & Ireland, said: “This latest contract will enable us to support The Christie as it continues to progress its openEHR digital strategy which will provide multiple benefits including better access to data and information, faster decision-making, and more-efficient management.
“Through our ePMA solution, we are committed to supporting The Christie to safely digitise its prescription processes while also providing improved access to data via the Better Meds integration with the trust’s in-house EPR and other systems.”